Antibiotics were prescribed for 89 nonhospitalized infections, 87% orally (n = 33 on plerixafor, n = 44 on G-CSF), and 12% topically (n = 5 on plerixafor and n = 6 on G-CSF) (Figure 4D and Supplemental Table 6). This evidence concerns the gene CSF3 and infection.